Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
10/2013
10/24/2013WO2013159064A1 Benzothiazol- 6 -yl acetic acid derivatives and their use for treating an hiv infection
10/24/2013WO2013159029A1 Compositions for topical treatment of microbial infections
10/24/2013WO2013158892A1 Thioredoxin protein inhibitors and uses thereof
10/24/2013WO2013158776A1 Compounds and methods for antiviral treatment
10/24/2013WO2013158516A1 Methods for treating or preventing influenza virus infection by administering a serine protease inhibitor
10/24/2013WO2013157697A1 Campsis grandiflora extract having hiv proliferation inhibiting activity, and agent for treating aids comprising same as active ingredient
10/24/2013WO2013157622A1 Hiv replication inhibitor
10/24/2013WO2013157584A1 Encapsulated formulation
10/24/2013WO2013157583A1 Novel carbapenem compound
10/24/2013WO2013157555A1 Novel aplysiatoxin derivative and anticancer agent containing same
10/24/2013WO2013157005A1 Methods and compositions for treating viral infections
10/24/2013WO2013156976A1 Prevention and treatment of non-viral infections in individuals treated with immunosuppressants
10/24/2013WO2013156957A1 Compounds for the prevention or treatment of infections with viruses of the flaviviridae family
10/24/2013WO2013156858A1 Materials and methods for prevention and treatment of viral infections
10/24/2013WO2013156534A1 Cross-reactive staphylococcus aureus antibody
10/24/2013WO2013156225A1 Optimizing ungual treatment by quantitative autoradiography
10/24/2013WO2013155888A1 Soybean peptide nutrient solution and preparation method and application thereof
10/24/2013WO2013155737A1 Pharmaceutical composition for treating aids and preparation method, quality controlling method and use thereof
10/24/2013WO2013134081A3 Halogenated compounds for photodynamic therapy
10/24/2013WO2013085550A3 V1v2 immunogens
10/24/2013WO2012134184A8 Novel cephalosporin derivatives and pharmaceutical compositions thereof
10/24/2013WO2012125746A9 Tricyclic gyrase inhibitors
10/24/2013WO2011085326A9 D- amino acids for use in treating biofilms
10/24/2013US20130281704 Salts of benzimidazole compound and use thereof
10/24/2013US20130281515 Cationic bis-urea compounds as effective antimicrobial agents
10/24/2013US20130281487 Solid Forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
10/24/2013US20130281470 Use of (R)-Penciclovir Triphosphate for the Manufacture of a Medicament for the Treatment of Viral Diseases
10/24/2013US20130280760 High purity lipopetides
10/24/2013US20130280330 Microsphere drug carrier, preparation method, composition and use thereof
10/24/2013US20130280303 Bone delivery system having a therapeutic agent
10/24/2013US20130280299 Viral vectors and their use in therapeutic methods
10/24/2013US20130280296 Dna vaccine against multitypes of avian influenza viruses and influenza virus-like particles comprising adjuvant-fused m2 protein
10/24/2013US20130280295 Aluminum compounds for use in therapeutics and vaccines
10/24/2013CA2850881A1 Benzothiazol- 6 -yl acetic acid derivatives and their use for treating an hiv infection
10/23/2013EP2653164A1 Type 5 and type 8 capsular polysaccharides of over-productive strains of S. aureus
10/23/2013EP2653158A1 Therapeutic agent for blood-brain barrier disruption syndrome
10/23/2013EP2653155A1 Ophthalmic composition for contact lens
10/23/2013EP2651975A1 Human monoclonal antibody with specificity for dengue virus serotype 1 e protein and uses thereof
10/23/2013EP2651959A2 Aminoglycosides:synthesis and use as antifungals
10/23/2013EP2651937A1 Imidazo [4, 5 -c]quinolin- 1 -yl derivative useful in therapy
10/23/2013EP2651936A1 Azaindoles as respiratory syncytial virus antiviral agents
10/23/2013EP2651934A1 Imidazopyridines as respiratory syncytial virus antiviral agents
10/23/2013EP2651933A1 Azabenzimidazoles as respiratory syncytial virus antiviral agents
10/23/2013EP2651928A2 Anti-viral compounds
10/23/2013EP2651927A1 Anti-viral compounds
10/23/2013EP2651926A2 Anti-viral compounds
10/23/2013EP2651925A2 Anti-viral compounds
10/23/2013EP2651923A1 Anti-viral compounds
10/23/2013EP2651922A1 Indoles as respiratory syncytial virus antiviral agents
10/23/2013EP2651920A2 Anti-viral compounds
10/23/2013EP2651893A1 Sulfur derivatives as chemokine receptor modulators
10/23/2013EP2651885A1 Anti-viral compounds
10/23/2013EP2651450A2 Azole pharmaceutical formulations for parenteral administration and methods for preparing and using the same as treatment of diseases sensitive to azole compounds
10/23/2013EP2651425A1 Algal extract-based composition for oro-dental use
10/23/2013EP2651416A1 Compounds useful for treating aids
10/23/2013EP2651408A1 S1p receptor agonists and use thereof in treating hiv infections
10/23/2013CN103370415A HBV treatment
10/23/2013CN103370333A Highly immunogenic HIV P24 sequences
10/23/2013CN103370317A Imidazo [4, 5-c] quinolin-1-yl derivative useful in therapy
10/23/2013CN103370070A Novel antibacterial compounds, methods of making them, and uses thereof
10/23/2013CN103369974A Nutritional formulations including human milk oligosaccharides and antioxidants and uses thereof
10/23/2013CN103361377A Method for generating HPV6 L1 (Human Papillomavirus) proteins by using hansenula polymorpha expression system
10/23/2013CN103361356A Marsupenaeus japonicus thymulin genes, and preparation method and applications of marsupenaeus japonicus thymulins
10/23/2013CN103361341A Genetic engineering expression and preparation methods of cecropin LL-37 and application thereof
10/23/2013CN103361328A Mediated integration HIV-1 (Human Immunodeficiency Virus-1) provirus gene knockout zinc finger nuclease as well as preparation method and application thereof
10/23/2013CN103361293A Pathogenic strain for Scophthalmus maximus and application thereof
10/23/2013CN103361280A Method for generating HPV11 L1 (Human Papillomavirus) by using hansenula polymorpha expression system
10/23/2013CN103361276A Saccharopolyspora spinosa HBERC-25376, culturing method thereof as well as separation method and application of active substances thereof
10/23/2013CN103361256A Mulberry leaf flu-proofing aromatic vinegar
10/23/2013CN103361201A Pepper seed soap
10/23/2013CN103360498A 一种抗鸡传染性法氏囊病的重组蛋白亚单位疫苗 An anti-IBD recombinant protein subunit vaccines
10/23/2013CN103360493A Cross-reactive and bispecific anti-IL 17A/F antibodies
10/23/2013CN103360491A Anti-helicobacter pylori FlaA protein antibody IgY, preparation method and application thereof
10/23/2013CN103360486A Antimicrobial peptides comprising arginine-and/or lysine-containing motif
10/23/2013CN103360485A Antimicrobial peptides comprising an arginine-and/or lysine-containing motif
10/23/2013CN103360479A Cow's milk staphylococcus aureus Efb protein and its preparation method and application thereof
10/23/2013CN103360477A Modified hepatitis C virus (HCV) Type 4 envelope E2 protein and application thereof
10/23/2013CN103360476A Modified hepatitis C virus (HCV) Type 2a envelope E2 protein and application thereof
10/23/2013CN103360475A Modified hepatitis C virus (HCV) Type 5 envelope E2 protein and application thereof
10/23/2013CN103360474A Modified hepatitis C virus (HCV) Type 3a envelope E2 protein and application thereof
10/23/2013CN103360473A Modified hepatitis C virus (HCV) Type 6 envelope E2 protein and application thereof
10/23/2013CN103360469A 抗微生物多肽 Antimicrobial peptides
10/23/2013CN103360467A Preparation method of broad-spectrum antibacterial polypeptide
10/23/2013CN103360464A Polypeptide, DNA molecule encoding polypeptide, vector, preparation method and application thereof
10/23/2013CN103360448A Single crystal form of metacavir ethanol solvent compound and preparation method thereof
10/23/2013CN103360447A Macrolide solid-state forms
10/23/2013CN103360446A Macrolide solid-state forms
10/23/2013CN103360445A Macrolide solid-state forms
10/23/2013CN103360440A Antibacterial aminoglycoside analogs
10/23/2013CN103360402A Salt of methoxysanguinarine derivative
10/23/2013CN103360401A Salts of methoxyl dictamnine derivatives
10/23/2013CN103360400A Salt for skimmianine derivates
10/23/2013CN103360398A Triazolopyrimidine HIV-1 retrovirus inhibitor and its preparation method and application thereof
10/23/2013CN103360385A Compound and medicament for treating MRSA (Methicillin-resistant Staphylococcus Aureus) infection
10/23/2013CN103360379A Novel oxazolidinone compound
10/23/2013CN103360378A Synthesis of oxadiazole derivatives and application of oxadiazole derivatives in field of antibacterial drugs
10/23/2013CN103360371A (E)-N-(2-amino-phenyl)-3-{1-[4-(1-methyl-1H-pyrazol-4-yl)-benzenesulfonyl]-1H-pyrrol-3-yl}-acrylamide salts
10/23/2013CN103360370A Synthesis of nitroimidazole derivatives and application of nitroimidazole derivatives in field of antibacterial drugs
10/23/2013CN103360351A Isopimarane diterpenoid compounds and application thereof
10/23/2013CN103360315A Heterocyclic aryloxyacetyl hydrazone derivative and its preparation method and application thereof
1 ... 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 ... 1798